Skip to main content
OpenTrials
Completed

NCT Number: NCT07452783

Circadian Clock Gene Expression in Periodontal Disease

This observational study aims to investigate whether periodontal inflammation is associated with alterations in the expression of circadian clock-related genes and proteins in gingival tissues. Circadian rhythms regulate many biological processes, including immune responses and inflammation. Although experimental studies suggest a link between circadian disruption and periodontal disease, human data under controlled chronotype conditions are limited.

A total of 60 systemically healthy, non-smoking individuals aged 22-45 years with comparable sleep patterns (intermediate chronotype and 6-9 hours of sleep) were included. Participants were classified as periodontally healthy, gingivitis, or stage III grade B periodontitis according to established diagnostic criteria. Gingival tissue samples were collected during clinically indicated procedures within a standardized morning time window (09:00-11:00).

Gene expression levels of circadian clock components (CLOCK, BMAL1, PER1-3, CRY1-2, Rev-Erb-β, ROR-α) and inflammatory mediators (IL-1β, IL-6, TNF-α, NF-κB, IFN-γ, RANKL, OPG) were analyzed using RT-qPCR, Western blot, and ELISA techniques. Associations between molecular findings and clinical periodontal parameters were evaluated.

The study seeks to clarify whether periodontal disease itself may disrupt local circadian regulatory mechanisms in gingival tissues.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Inonu University Faculty of Dentistry

Malatya, 44210, Turkey (Türkiye)

About this study

Circadian rhythms are generated through transcriptional-translational feedback loops involving core clock genes such as CLOCK, BMAL1, PER1-3, CRY1-2, ROR-α, and REV-ERB-β. These molecular oscillators regulate immune function, inflammatory signaling, and bone metabolism. Experimental evidence suggests that circadian dysregulation may aggravate periodontal inflammation and alveolar bone loss; however, comprehensive human data under controlled chronotype conditions remain limited.

This single-center, observational case-control study includes 60 systemically healthy, non-smoking individuals (30 males, 30 females) aged 22-45 years. Chronotype was determined using the Munich Chronotype Questionnaire, and only individuals with intermediate chronotype and self-reported sleep duration between 6 and 9 hours were included to minimize circadian variability.

Participants were classified into three groups (n=20 per group): periodontally healthy, gingivitis, and stage III grade B periodontitis according to the 2017 World Workshop criteria. Comprehensive periodontal examination included plaque index, gingival index, bleeding on probing, probing depth, and clinical attachment loss measurements. Gingival tissue biopsies were obtained during clinically indicated procedures and collected between 09:00 and 11:00 a.m. to standardize circadian timing. Samples were stored at -80°C until molecular analysis.

Total RNA was extracted from gingival tissues, and gene expression was quantified using RT-qPCR with normalization to β-actin and analysis via the 2^-ΔΔCT method. Protein expression of circadian clock components was assessed by Western blot, and inflammatory cytokine levels (IL-1β, IL-6) were quantified by ELISA. Correlation analyses were performed to evaluate associations between circadian gene expression, inflammatory mediators, and clinical periodontal parameters.

The primary objective is to determine whether periodontal inflammation is associated with disruption of gingival circadian clock gene and protein expression in individuals with comparable chronotype profiles.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older
  • Systemically healthy individuals
  • Presence of at least 20 natural teeth
  • Individuals classified as periodontally healthy, gingivitis, or Stage III Grade B periodontitis according to the 2018 classification of periodontal diseases
  • Willingness to provide written informed consent

Exclusion criteria

  • Presence of any systemic disease affecting periodontal status (e.g., diabetes mellitus, autoimmune diseases, cardiovascular diseases)
  • Use of antibiotics or anti-inflammatory medications within the previous 3 months
  • Periodontal therapy within the last 6 months
  • Current smokers or individuals who quit smoking within the past 5 years
  • Pregnancy or lactation
  • Use of medications known to influence immune or inflammatory responses
  • History of systemic conditions that may affect wound healing

Treatment and study plan

Gingival Tissue Biopsy

Procedure

Collection of gingival tissue samples from interproximal sites during clinically indicated periodontal procedures for molecular and protein expression analyses.

Primary outcomes

  1. Relative mRNA Expression Levels of Circadian Clock Genes in Gingival Tissue

    Time frame: At the time of gingival tissue collection (single time point)

    Quantitative assessment of BMAL1, CLOCK, PER1, PER2, PER3, CRY1, CRY2, REV-ERBβ, and ROR-α mRNA expression levels in gingival tissue samples using real-time quantitative polymerase chain reaction (RT-qPCR). Expression levels will be calculated as relative fold changes normalized to housekeeping genes and compared among periodontally healthy, gingivitis, and Stage III Grade B periodontitis groups.

Secondary outcomes

  1. Pro-inflammatory Cytokine Expression Levels

    Time frame: At the time of tissue collection

    Relative mRNA expression levels of IL-1β, IL-6, TNF-α, and IFN-γ in gingival tissue samples assessed by RT-qPCR and compared among study groups.

  2. NF-κB Expression Level

    Time frame: At the time of tissue collection

    Relative expression level of NF-κB in gingival tissue samples determined by molecular analysis and compared among study groups.

  3. Bone Metabolism Markers

    Time frame: At the time of tissue collection

    Relative mRNA expression levels of RANKL and OPG in gingival tissue samples and evaluation of the RANKL/OPG ratio among study groups.

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Official study title

Periodontal Inflammation Is Associated With Disruption of Gingival Circadian Clock Gene and Protein Expression in Individuals With Comparable Chronotype Profiles

Acronym: PERIOCLOCK

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Mar 5, 2026
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.